Mariner Investment Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

Mariner Investment Group’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-45,969	Closed	-$503K	–	109
2016 Q2	$503K	Buy	45,969 +10,149	+28%	+$99.2K	0.17%	96
2016 Q1	$328K	Sell	35,820 -21,611	-38%	-$178K	0.09%	135
2015 Q4	$557K	Sell	57,431 -27,462	-32%	-$265K	0.12%	146
2015 Q3	$741K	Buy	84,893 +5,014	+6%	+$46.8K	0.15%	138
2015 Q2	$807K	Buy	79,879 +3,941	+5%	+$45.8K	0.21%	116
2015 Q1	$1.02M	Buy	75,938 +17,910	+31%	+$235K	0.27%	95
2014 Q4	$745K	Sell	58,028 -16,239	-22%	-$186K	0.13%	143
2014 Q3	$806K	Hold	74,267	–	–	0.17%	117
2014 Q2	$954K	Buy	74,267 +47,760	+180%	+$519K	0.18%	110
2014 Q1	$274K	Buy	+26,507	New	+$298K	0.06%	153

Other funds holding IRWD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mariner Investment Group's IRWD Position: Q3 2016 in Review

Mariner Investment Group sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2016, closing a stake of 45,969 shares — an estimated $503K sold.

Mariner Investment Group first reported a position in IRWD in Q1 2014 and held it in 10 quarters. The position peaked at $1.02M in Q1 2015. 155 funds tracked by Wall St. Rank hold IRWD as of Q3 2016.

Mariner Investment Group reported no remaining Ironwood Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
Mariner Investment Group sold 45,969 Ironwood Pharmaceuticals shares in Q3 2016, an estimated $503K.
Mariner Investment Group first reported a position in Ironwood Pharmaceuticals in Q1 2014 and held it in 10 quarters.
Mariner Investment Group's Ironwood Pharmaceuticals position peaked at $1.02M in Q1 2015.
155 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2016.

Based on Mariner Investment Group's 13F filing for Q3 2016, filed 3 Nov 2016.